BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20031719)

  • 1. Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry.
    Mehta SK; Frutkin AD; Lindsey JB; House JA; Spertus JA; Rao SV; Ou FS; Roe MT; Peterson ED; Marso SP;
    Circ Cardiovasc Interv; 2009 Jun; 2(3):222-9. PubMed ID: 20031719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncardiac surgery and bleeding after percutaneous coronary intervention.
    To AC; Armstrong G; Zeng I; Webster MW
    Circ Cardiovasc Interv; 2009 Jun; 2(3):213-21. PubMed ID: 20031718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry.
    Ahmed B; Piper WD; Malenka D; VerLee P; Robb J; Ryan T; Herne M; Phillips W; Dauerman HL
    Circ Cardiovasc Interv; 2009 Oct; 2(5):423-9. PubMed ID: 20031752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report.
    Brener SJ; Milford-Beland S; Roe MT; Bhatt DL; Weintraub WS; Brindis RG;
    Am Heart J; 2008 Jan; 155(1):140-6. PubMed ID: 18082505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications.
    Fuchs S; Kornowski R; Teplitsky I; Brosh D; Lev E; Vaknin-Assa H; Ben-Dor I; Iakobishvili Z; Rechavia E; Battler A; Assali A
    Cardiovasc Revasc Med; 2009; 10(2):88-93. PubMed ID: 19327670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry.
    Rao SV; McCoy LA; Spertus JA; Krone RJ; Singh M; Fitzgerald S; Peterson ED
    JACC Cardiovasc Interv; 2013 Sep; 6(9):897-904. PubMed ID: 24050858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of home warfarin use on the treatment and outcomes of patients undergoing percutaneous coronary intervention.
    Aggarwal A; Dai D; Rumsfeld JS; Klein LW; Roe MT
    Am J Cardiol; 2008 May; 101(10):1413-7. PubMed ID: 18471451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction.
    Hermanides RS; Ottervanger JP; Dambrink JH; de Boer MJ; Hoorntje JC; Gosselink AT; Suryapranata H; van 't Hof AW
    EuroIntervention; 2010 May; 6(1):106-11. PubMed ID: 20542805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registry.
    Yan BP; Gurvitch R; Duffy SJ; Clark DJ; Sebastian M; New G; Warren R; Lefkovits J; Lew R; Brennan AL; Reid C; Andrianopoulos N; Ajani AE
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):928-36. PubMed ID: 18044763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting vascular complications in percutaneous coronary interventions.
    Piper WD; Malenka DJ; Ryan TJ; Shubrooks SJ; O'Connor GT; Robb JF; Farrell KL; Corliss MS; Hearne MJ; Kellett MA; Watkins MW; Bradley WA; Hettleman BD; Silver TM; McGrath PD; O'Mears JR; Wennberg DE;
    Am Heart J; 2003 Jun; 145(6):1022-9. PubMed ID: 12796758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.
    De Carlo M; Borelli G; Gistri R; Ciabatti N; Mazzoni A; Arena M; Petronio AS
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):408-15. PubMed ID: 19360863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry).
    Byrne J; Spence MS; Fretz E; Mildenberger R; Chase A; Berry B; Pi D; Janssen C; Klinke P; Hilton D
    Am J Cardiol; 2009 Feb; 103(4):507-11. PubMed ID: 19195511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).
    Akhter N; Milford-Beland S; Roe MT; Piana RN; Kao J; Shroff A
    Am Heart J; 2009 Jan; 157(1):141-8. PubMed ID: 19081410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.
    Yan BP; Clark DJ; Buxton B; Ajani AE; Smith JA; Duffy SJ; Shardey GC; Skillington PD; Farouque O; Yii M; Yap CH; Andrianopoulos N; Brennan A; Dinh D; Reid CM; ;
    Heart Lung Circ; 2009 Jun; 18(3):184-90. PubMed ID: 19268632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™.
    Mathews R; Peterson ED; Chen AY; Wang TY; Chin CT; Fonarow GC; Cannon CP; Rumsfeld JS; Roe MT; Alexander KP
    Am J Cardiol; 2011 Apr; 107(8):1136-43. PubMed ID: 21324428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of bleeding and blood transfusion in percutaneous coronary intervention.
    Rao SV
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S18-26. PubMed ID: 17917617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome in patients transferred for percutaneous coronary intervention (a national registry of myocardial infarction 2/3/4 analysis).
    Shavelle DM; Rasouli ML; Frederick P; Gibson CM; French WJ;
    Am J Cardiol; 2005 Nov; 96(9):1227-32. PubMed ID: 16253587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model.
    Klein LW; Shaw RE; Krone RJ; Brindis RG; Anderson HV; Block PC; McKay CR; Hewitt K; Weintraub WS;
    Am J Cardiol; 2005 Jul; 96(1):35-41. PubMed ID: 15979429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.